Zoekresultaten

Carlos Mota develops new in vitro models to study kidney diseases at MERLN. For his NEPRHON project, he received the ERC Consolidator Grant.

ReGEN Biomedical, a Maastricht University spin-off, has entered into a partnership with Demcon. Operating on an international level, this technology company will become a shareholder and will be making strides in regenerative medicine at Brightlands Maastricht Health Campus, together with ReGEN, with a...